Theranos Investor Conference Presentation Deck slide image

Theranos Investor Conference Presentation Deck

Lymphocyte Subset: Matrix Comparison Study Overview Population Sample type and matrix Analyzers Study design Analysis Apparently healthy subjects K₂-EDTA capillary and venous whole blood 6 miniLab TBNK on Becton Dickinson FACSCanto II 1 replicate each matrix on miniLab 2 replicates venous on comparator method Passing-Bablok regression analysis and calculate median bias This technology has not been cleared or approved by the FDA and is not for sale in the United States. theranos 69
View entire presentation